Chicago Partners Investment Group 13F: New $6.6M Stake in PATH

Key Points

  • Chicago Partners Investment Group took a new position of 469,188 shares in UiPath, valued at $6,629,633, as reported in their latest Form 13F filing.
  • UiPath's stock recently traded around $14.06, which is below its 50-day moving average of $14.46 and its 52-week high of $19.84.
  • The firm now holds 0.44% of its reported portfolio in UiPath, ranking it 29th out of 1,660 positions.

Get UiPath text alerts

We text you when insiders, Congress, analysts or big funds move on $PATH.

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated UiPath, Inc. alert may contain errors. Disclosures

Chicago Partners Investment Group opened a new position of 469,188 shares in UiPath, Inc. (NYSE: PATH) in a filing on October 27, 2026. The reported value of this stake is approximately $6,629,633. This marks a significant entry for the firm, as it did not hold any shares prior to this filing.

PATH UiPath, Inc.
$14.30 -9.95% year to date
Daily close · Oct 26, 2026
13F track record

Chicago Partners Investment Group vs. the S&P 500

YTD return +6.41% hypothetical
All-time return +6.41% S&P 500 +5.83%
vs. S&P 500 +0.58% ahead of the index

Hypothetical returns from Chicago Partners Investment Group's disclosed trades, not real profit or advice. How we model this.

Where UiPath Fits in Chicago Partners Investment Group's Portfolio

This new position represents about 0.44% of Chicago Partners' total reported value of approximately $1.51 billion. The stake ranks 29th among the firm's 1,660 positions.

Other Institutional Activity in UiPath

Tetragon Partners GP Ltd. holds 30,950,000 shares of UiPath, valued at about $435.2 million, after increasing its holdings by 5,742,312 shares. Two Sigma Investments, LP also has a significant position with 15,034,443 shares worth approximately $211.4 million, having boosted its stake by 11,475,068 shares. Additionally, Senvest Management LLC owns 12,085,222 shares, valued at about $169.9 million, after increasing its holdings by 4,300,359 shares.

UiPath, Inc. Stock Down 0.5%

UiPath shares recently traded around $14.06, which is below the closing price of $14.30 on October 26, 2026. The stock is currently below its 50-day moving average of $14.46 and about 29.1% under its 52-week high of $19.84. However, it is above its 52-week low of $9.20, reflecting a 52.8% increase from that point.

Recent Earnings

UiPath reported trailing twelve-month revenue of approximately $1.72 billion, with a net margin of 21.0% and a return on equity of 20.0%. The next earnings report is scheduled for December 2, 2026.

Insider Buying and Selling at UiPath, Inc.

Recently, several insiders sold shares in UiPath. Chief Technology Officer Raghavendra Malpani sold 29,564 shares at an average price of $13.51 on October 9, 2026, totaling approximately $399,265. Officer Brad C. Brubaker sold 27,404 shares at $13.63 on October 12, 2026, valued at around $373,555. Additionally, CEO Daniel Dines sold 2,500,000 shares on October 16, 2026, with a total value of about $33.1 million. On October 22, 2026, Raghavendra Malpani sold another 29,565 shares at $14.00, totaling approximately $413,963.

Analysts Set New Price Targets

On September 24, 2026, BMO Capital maintained a Market Perform rating with a price target of $15.00, while Canaccord Genuity and TD Cowen both maintained Hold ratings with targets of $14.00 and $15.00, respectively. UBS also maintained a Neutral rating with a target of $14.00. DA Davidson downgraded its rating to Underperform with a target of $10.00 on September 28, 2026. The consensus recommendation remains a Hold with a mean price target of $15.32 based on 17 analyst opinions.

About UiPath

UiPath, Inc. is a technology company that provides robotic process automation (RPA) solutions. It offers an integrated software platform that allows AI agents and robots to work together in coordinated workflows. The firm operates primarily in the United States, Romania, the United Kingdom, and the Netherlands.

Bottom Line

Investors should keep an eye on UiPath's next earnings report on December 2, 2026. Chicago Partners' new stake adds to the growing interest in the company as it navigates its position in the competitive automation space.

Source: Chicago Partners Investment Group's 13F filing on $PATH (Oct 27, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts

Get $PATH trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions